PRPH 0.78 (-45.45%)
US74345W1080Drug ManufacturersDrug Manufacturers - Specialty & Generic

ProPhase Labs (PRPH) Competitor Comparison

We are evaluating the key criteria listed to compare ProPhase Labs (PRPH) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Performance 5 years - PRPH ranking 29 / 54

These are the competitors of ProPhase Labs in the industry Drug Manufacturers - Specialty & Generic ranked by performance 5 years
1. Harrow Health HROW
976.02
2. Amneal Pharmaceuticals AMRX
223.33
3. Avadel Pharmaceuticals AVDL
197.94
4. Amphastar Pharmaceuticals AMPH
152.93
5. Teva Pharmaceutical Industries TEVA
100.59
6. Collegium Pharmaceutical COLL
78.96
7. Supernus Pharmaceuticals SUPN
74.62
8. Zoetis ZTS
46.35
9. Kolinpharma KIP.MI
42.45
10. Vifor Pharma G2AB.F
39.09
11. Alvotech ALVO
33.58
12. PetIQ PETQ
23.72
13. Alimera Sciences ALIM
23.11
14. Catalent CTLT
20.63
15. Green Thumb Industries R9U2.F
15.97
16. Kamada KMDA
14.07
17. Phibro Animal Health PAHC
3.52
18. ANI Pharmaceuticals ANIP
0.31
19. Evolus EOLS
-9.58
20. Journey Medical DERM
-35.06
21. Regencell Bioscience Holdings RGC
-42.33
22. Linc LNC
-42.66
23. Perrigo PRGO
-46.96
24. Elanco Animal Health ELAN
-47.66
25. Taro Pharmaceutical Industries TARO
-50.4
26. Organogenesis Holdings ORGO
-54.08
27. Ironwood Pharmaceuticals IRWD
-54.24
28. Curaleaf Holdings CURLF
-55.25
29. ProPhase Labs PRPH
-56.67
30. Pacira BioSciences PCRX
-59.57
31. Bausch Health Companies BHC
-63.98
32. Alpha Teknova TKNO
-65.44
33. Embecta EMBC
-67.63
34. Neoleukin Therapeutics NLTX
-70.42
35. Cronos Group CRON
-74.84
36. Emergent BioSolutions EBS
-78.26
37. Cumberland Pharmaceuticals CPIX
-79.41
38. Jupiter Wellness JUPW
-80
39. Zynerba Pharmaceuticals ZYNE
-82.07
40. Procaps Group PROC
-84.26
41. Societal CDMO SCTL
-85.58
42. Ayr Wellness 3KJB.F
-86.37
43. Relmada Therapeutics RLMD
-86.81
44. SCYNEXIS SCYX
-89.08
45. Ascend Wellness Holdings AAWH
-89.54
46. OptiNose OPTN
-90.87
47. Theratechnologies THTX
-91.2
48. Tilray Brands TLRY
-93.33
49. Solid Biosciences SLDB
-96.42
50. Universe Pharmaceuticals UPC
-98.29
51. Eagle Pharmaceuticals EGRX
-98.48
52. Biofrontera BFRI
-98.78
53. Flora Growth FLGC
-99.09
54. Clever Leaves Holdings CLVR
-100

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.